Lexston Life Sciences Corp.'s total assets for Q3 2026 were C$1.16M, an increase of 24.75% from the previous quarter. TSE:LEXT total liabilities were C$130.55K for the fiscal quarter, a -6.09% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.